Evidence map›Paper›PMID 38100072›Full record

ArticleInnere Medizin (Heidelberg, Germany)2024

[Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].

Jannik Fasse, Henning Trawinski, Michael Hardt, Christoph Lübbert

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Innere Medizin (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jannik FasseBereich Infektiologie und Tropenmedizin, Medizinische Klinik I (Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie), Universitätsklinikum Leipzig, Liebigstraße 20, Haus 4, 04103, Leipzig, Deutschland. jannik.fasse@medizin.uni-leipzig.de.
Henning TrawinskiBereich Infektiologie und Tropenmedizin, Medizinische Klinik I (Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie), Universitätsklinikum Leipzig, Liebigstraße 20, Haus 4, 04103, Leipzig, Deutschland.
Michael HardtStandort Leipzig, Landesuntersuchungsanstalt für das Gesundheits- und Veterinärwesen Sachsen (LUA), Leipzig, Deutschland.
Christoph LübbertBereich Infektiologie und Tropenmedizin, Medizinische Klinik I (Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie), Universitätsklinikum Leipzig, Liebigstraße 20, Haus 4, 04103, Leipzig, Deutschland.
University Hospital Leipzig · DEKlinikum St. Georg · DELandesuntersuchungsanstalt Sachsen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germany has been considered free of terrestrial rabies since 2008 as a result of intensive vaccination and surveillance efforts but reservoirs of the lyssaviruses EBLV‑1 and EBLV‑2 persist in bat colonies and thus pose a potential risk of infection. We report on a patient who suffered a bat bite in an urban setting in which European bat lyssavirus 1 (EBLV-1) was detected in the euthanized bat. We performed active and passive postexposure prophylaxis (PEP). This case study illustrates the ongoing risk of rabies infection due to close bat contacts in Germany and is intended to sensitize primary care physicians to take such exposure events seriously and to perform a regular PEP including administration of rabies immunoglobulin.

Indexed as

Bites and StingsChiropteraLyssavirusPost-Exposure ProphylaxisRabiesAnimalsGermanyHumansMaleRabies VaccinesRhabdoviridae InfectionsRabies VaccinesBite injuryEuropean bat lyssavirus 1Postexposure prophylaxisRabiesVaccination

Identifiers

PMID38100072
PMCPMC11136739
OpenAlexW4389787652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.